Ampicillin, cloxacillin
Sold as Ranclosil, Ampoxin, Megamox, Megamox s
(2S,5R,6R)-6-[[3-(2-Chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
Drag to rotate. Structure from PubChem CID 6098.
Background
Registration
- Applicants
- 3
- Registrations
- 6
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Oethmaan Biosims (Pty) Ltd | Ranclosil | injection | 310533 | Not determined | None |
| Unichem SA (Pty) Ltd | Ampoxin | 250, 500, 1000 | A380385, A380386, A380388 | Not determined | None |
| Pharmacare limited û woodmeadCancelled | Megamox, Megamox s | 500 mg | Z0355, Z0356 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Ranclosil injection EACH 10,0 ml VIAL CONTAINS AMPICILLIN SODIUM EQUIVALENT TO AMPICILLIN 250,0 mg CLOXACILLIN SODIUM EQUIVALENT TO CLOXACILLIN 250,0 mg | Injection | 31053331/20.1.2/0533 | Registered | Not determined | None |
| Ampoxin 250 EACH VIAL CONTAINS AMPICILLIN SODIUM EQUIVALENT TO AMPICILLIN 125,0 mg CLOXACILLIN SODIUM EQUIVALENT TO CLOXACILLIN 125,0 mg | 250 | A380385A38/20.1.2/0385 | Registered | Not determined | None |
| Ampoxin 500 EACH VIAL CONTAINS AMPICILLIN SODIUM EQUIVALENT TO AMPICILLIN 250,0 mg CLOXACILLIN SODIUM EQUIVALENT TO CLOXACILLIN 250,0 mg | 500 | A380386A38/20.1.2/0386 | Registered | Not determined | None |
| Ampoxin 1000 EACH VIAL CONTAINS AMPICILLIN SODIUM EQUIVALENT TO AMPICILLIN 500,0 mg CLOXACILLIN SODIUM EQUIVALENT TO CLOXACILLIN 500,0 mg | 1000 | A380388A38/20.1.2/0388 | Registered | Not determined | None |
| Megamox 500 MG EACH CAPSULE CONTAINS AMPICILLIN TRIHYDRATE EQUIVALENT TO AMPICILLIN 250 mg CLOXACILLIN SODIUM EQUIVALENT TO CLOXACILLIN 250 mg | 500 mg | Z0355Z/20.1.2/355 | Cancelled | Not determined | None |
| Megamox s EACH 5 ml SYRUP CONTAINS AMPICILLIN TRIHYDRATE EQUIVALENT TO AMPICILLIN 125 mg CLOXACILLIN SODIUM EQUIVALENT TO CLOXACILLIN 125 mg | Not listed | Z0356Z/20.1.2/356 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Ampicillin
- except when listed elsewhere in the Schedules and except intra-mammary preparations thereof, containing tracer dye(s) and intended for the treatment of mastitis in cattle and registered in terms of the provisions of the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947. (Act 36 of 1947)
Consolidated Schedules 06 July 2026, lines 5240 to 5242
S4: Cloxacillin
- except when listed elsewhere in the Schedules and except intra-mammary preparations thereof, containing tracer dye(s) and intended for the treatment of mastitis in cattle and registered in terms of the provisions of the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947 (Act 36 of 1947).
Consolidated Schedules 06 July 2026, lines 5862 to 5864
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.